ZURICH (Reuters) – Britain’s healthcare watchdog (NICE) recommended Roche’s medicine Gazyvaro for previously untreated advanced follicular lymphoma patients after initially rejecting the Swiss drugmaker’s medicine last year as too expensive.
Source: Reuters Medical News